Intermittent Hypoxia in Persons With Multiple Sclerosis

Abroad (travel likely)Recruiting

Conditions

Multiple Sclerosis · Multiple Sclerosis-Relapsing-Remitting · Multiple Sclerosis, Secondary Progressive

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shirley Ryan AbilityLab, Chicago, Illinois, United States
Contact: Study coordinator (Alexander Barry, MS, CCRC) · abarry@sralab.org · 3122381435
Contact: Principal Investigator (Milap Sandhu, PT, PhD)
Molly Bright, D.Phil. (Sub-investigator)

Study leads

Milap Sandhu, Pt, PhD
Principal Investigator
Shirley Ryan AbilityLab

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE2

Baltimore, United States · New York, United States

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

Chronic Inflammatory Demyelinating Polyneuropathy · Myasthenia Gravis · Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE1

Palo Alto, United States · New York, United States

Cohort Study on Neuroimmune Diseases in the Reproductive Age

Neuromyelitis Optica Spectrum Disorders (NMOSD) · Multiple Sclerosis · Autoimmune Encephalitis

Abroad (travel likely)Recruiting

Guangzhou, China

Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)

NMO Spectrum Disorder · MRI · Multiple Sclerosis

Abroad (travel likely)Recruiting

Beijing, China